Merck's gross profit for the
three
months ended in Jun. 2023 was $11,011 Mil. Merck's gross profit for the trailing twelve months (TTM) ended in Jun. 2023 was $42,546 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Merck's gross profit for the
three
months ended in Jun. 2023 was $11,011 Mil. Merck's Revenue for the
three
months ended in Jun. 2023 was $15,035 Mil. Therefore, Merck's Gross Margin % for the quarter that ended in Jun. 2023 was 73.24%.
Merck had a gross margin of 73.24% for the quarter that ended in Jun. 2023 => Durable competitive advantage
During the past 13 years, the highestGross Margin % of Merck was 72.96%. The lowest was 60.30%. And the median was 67.51%.
Merck Gross Profit Historical Data
The historical data trend for Merck's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Merck Annual Data
Trend
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Gross Profit
28,785.00
27,105.00
27,900.00
35,078.00
41,872.00
Merck Quarterly Data
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Gross Profit
10,377.00
11,025.00
9,949.00
10,561.00
11,011.00
Competitive Comparison
For the Drug Manufacturers - General subindustry, Merck's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merck Gross Profit Distribution
For the Drug Manufacturers industry and Healthcare sector, Merck's Gross Profit distribution charts can be found below:
* The bar in red indicates where Merck's Gross Profit falls in comparison to its industry or sector. The grey bar indicates the Gross Profit's extreme value range as defined by GuruFocus.
Merck Gross Profit Calculation
Gross Profit is the different between the sale prices and the cost of buying or producing the goods.
Merck's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as
Gross Profit for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $42,546 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
Merck's Gross Margin % for the quarter that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Merck (NYSE:MRK) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Merck had a gross margin of 73.24% for the quarter that ended in Jun. 2023 => Durable competitive advantage
Merck Gross Profit Related Terms
Thank you for viewing the detailed overview of Merck's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
0.39(0.37%) Volume: 4,965,330 11:09PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
MRK has been successfully added to your 
